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OBJECTIVES The study compared the adjusted risk for developing atrial fibrillation (AF) after minimally
invasive direct coronary artery bypass surgery (MIDCAB) and coronary artery bypass graft
surgery (CABG).
BACKGROUND Atrial fibrillation results in increased morbidity and delays hospital discharge after CABG.
Recently, MIDCAB has been explored as an alternative to CABG. Because of differences in
surgical approach between the two procedures, the incidence of AF may differ.
METHODS Randomly selected patients undergoing CABG and MIDCAB were examined. Baseline
variables and postoperative course were recorded through review of medical record data.
RESULTS The MIDCAB patients were younger than CABG patients (64 6 12 vs. 67 6 10, p , 0.04)
and had less extensive coronary artery disease (53% of MIDCAB vs. 3% of CABG had
single-vessel disease, while 15% of MIDCAB vs. 69% of CABG had triple-vessel disease,
p , 0.001 for overall group comparisons). No other differences in clinical or treatment data
were noted. Postoperative AF occurred less often after MIDCAB (23% vs 39%, p 5 0.02).
Other significant factors associated with postoperative AF included age (p 5 0.0024), prior
AF (p 5 0.0007), left main disease (p 5 0.01), number of vessels bypassed (p 5 0.009),
absence of postoperative beta-blocker therapy (p 5 0.0001), and a serious postoperative
complication (p 5 0.0018). Because of differences between CABG and MIDCAB patients,
multivariate logistic analysis was performed to determine independent predictors of postop-
erative AF. The type of surgery (CABG vs. MIDCAB) was no longer a significant predictor
of postoperative AF (estimated relative risk for AF in CABG vs. MIDCAB patients: 1.57,
95% confidence interval (0.82–2.52).
CONCLUSIONS Although AF appears to be less common after MIDCAB than after CABG, the lower
incidence is due to different clinical characteristics of patients undergoing these procedures.
(J Am Coll Cardiol 2000;36:1884–8) © 2000 by the American College of Cardiology
Atrial fibrillation (AF) is the most common arrhythmia
occurring after coronary artery bypass graft surgery
(CABG), and results in increased morbidity and prolonged
postoperative hospital stay (1–7). Proposed hypotheses to
explain the high incidence of AF after cardiac surgery
include the increased adrenergic drive in the postoperative
period (8–10), atrial ischemia/necrosis associated with atri-
otomy and incomplete or prolonged atrial cardioplegia
(4,11–13), electrolyte abnormalities during and following
cardiopulmonary bypass (14–16), or pericarditis (17,18).
Minimally invasive direct coronary artery bypass
(MIDCAB) surgery on a beating heart through a left
thoracotomy or limited median sternotomy incision has
recently been explored as an alternative to CABG (19–24).
The advantages of MIDCAB include the absence of car-
diopulmonary bypass and the smaller incisions, presumably
contributing to a more rapid postoperative recovery with
shorter hospital stays and decreased costs.
It can be hypothesized that the incidence of AF after
MIDCAB would be lower than that reported following
CABG due to the less invasive surgical technique. In fact,
earlier reports on the MIDCAB procedure have demon-
strated a low incidence of postoperative AF (24–27). It is
unclear, however, whether the lower incidence of AF in
these groups relates to the healthier population of patients
typically referred for MIDCAB. The two purposes of this
study were to compare the incidence of AF in patients
undergoing MIDCAB to the incidence seen in patients
referred for traditional CABG, and to determine whether
the mode of coronary artery bypass is an independent
predictor of postoperative AF.
METHODS
Patient eligibility. Consecutive patients undergoing coro-
nary artery bypass at The Valley Hospital during the period
January 1996 through May 1999 were identified through a
department log. Approximately eight times as many CABG
procedures were performed over this period compared with
MIDCAB. Because selection of consecutive patients might
bias the results of our analysis in favor of the MIDCAB
group who were more recently operated and received more
contemporary postoperative care, we randomly selected
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patients over a similar time period. The hospital charts for
these selected groups of patients were then examined in
detail. Patients undergoing concomitant valvular or septal
repair surgery were excluded. Only patients who were in
normal sinus rhythm on preoperative electrocardiogram
(ECG) were eligible for the study.
Data collection. Baseline clinical variables, method of
bypass (CABG vs. MIDCAB), and postoperative course,
including the development of postoperative AF or the
occurrence of other serious postoperative events, were re-
corded through careful chart review. A postoperative event
included any one or more of the following events: significant
postoperative infection (pneumonia, wound infection, bac-
teremia), a significant neurologic event (cerebral vascular
accidents or seizures), respiratory failure requiring mechan-
ical ventilation over 48 h, peripheral or pulmonary emboli,
acute renal failure, clinically significant ventricular arrhyth-
mias or high-grade atrioventricular (AV) block, repeat
surgery, or wound disruption. The development of AF was
defined as any episode of AF noted by ECG or telemetry
monitoring, or documented in the chart by a member of the
healthcare staff, lasting for 1 h or more. The postoperative
day that AF was first detected, the development of recurrent
AF, and the longest duration of AF were also recorded.
Statistical analysis. Statistical analyses were performed
using SPSS (Statistical Package for the Social Sciences).
Baseline characteristics and postoperative course for the two
surgical techniques were compared by chi-square tests for
discrete outcomes and the Student t-tests for continuous
outcomes. Logistic regression was employed to obtain
unadjusted and adjusted odds ratios (ORs) for all predictors
of postoperative AF. Because ORs overestimate the relative
risk (RR) when the rate of the event is greater than 10%, we
evaluated the univariate OR for developing AF in CABG
patients compared with MIDCAB patients. Logistic regres-
sion analysis was then used to test whether the difference in
rates of AF between the MIDCAB and CABG groups was
still significant after adjusting for possible AF risk factors.
All ORs were corrected to obtain a closer estimation of the
RR, as proposed by Zhang and Yu (28).
RESULTS
Baseline clinical variables and hospital course. Two hun-
dred and nine patients (101 MIDCAB patients and 108
CABG patients) were examined. The baseline clinical
characteristics of these patients are depicted in Table 1. The
MIDCAB patients were younger (64 6 12 vs. 67 6 10
years, p 5 0.04), were less likely to have had a history of
prior cardiac surgery (2% vs. 12%, p 5 0.006) and had less
extensive coronary artery disease (53% of MIDCAB pa-
tients vs. 3.0% of CABG patients had single-vessel disease,
whereas 15% of MIDCAB patients vs. 69% of CABG
patients had triple-vessel disease, p , 0.001 for overall
group comparisons). There was a trend toward higher left
ventricular ejection fractions (LVEF) in the MIDCAB
group (54 6 11 vs. 51 6 12, p 5 0.10). No significant
differences existed in gender, or the incidence of diabetes,
hypertension, prior myocardial infarction, prior AF, preop-
erative use of beta-blockers, or left ventricular hypertrophy
between the two groups.
Table 2 depicts the intra-operative and postoperative
course for the two surgical techniques. As a result of the less
extensive coronary artery disease, MIDCAB patients re-
ceived significantly fewer bypass grafts (1.4 6 0.8 vs. 3.3 6
1.0, p , 0.001). There was a trend toward a lower incidence
of postoperative events for MIDCAB patients (19% vs.
30%, p 5 0.08). The postoperative length of stay was
significantly shorter in MIDCAB patients (6.6 6 3.6 vs.
8.8 6 5.8, p 5 0.001). The percentage of patients treated
with beta-blocking agents after surgery was similar for the
two groups.
Postoperative atrial fibrillation. Twenty-three (23%) of
MIDCAB patients and 42 (39%) of CABG patients devel-
oped AF after surgery (p 5 0.02). The AF occurred 2.4 6
1.2 days after MIDCAB versus 3.1 6 1.9 days after CABG
Abbreviations and Acronyms
AF 5 atrial fibrillation
CABG 5 coronary artery bypass graft surgery
MIDCAB 5 minimally invasive direct coronary artery
bypass surgery
Table 1. Baseline Clinical Variables
Clinical Variable MIDCAB CABG p Value
Age (yrs) 64 6 12 67 6 10 0.04
Male gender 75% 71% 0.54
Diabetes 23% 32% 0.13
Hypertension 66% 67% 1.0
Prior AF 6% 11% 0.40
Prior MI 34% 38% 0.57
Prior CABG 2% 12% 0.006
Lung disease 10% 11% 0.82
LVH on ECG 15% 8% 0.19
Preoperative BB 71% 70% 1.00
LVEF 54 6 11 51 6 12 0.10
Single-vessel disease 53% 3% , 0.001*
Triple-vessel disease 15% 69%
*The p value for overall test of difference in number of diseased vessels.
AF 5 atrial fibrillation; BB 5 beta-blockers; CABG 5 coronary artery bypass
graft surgery; ECG 5 electrocardiogram; LVEF 5 left ventricular ejection fraction;
LVH 5 left ventricular hypertrophy; MI 5 myocardial infarction; MIDCAB 5
minimally invasive direct coronary artery bypass surgery.
Table 2. Intraoperative and Postoperative Course for CABG
Versus MIDCAB
Clinical Variable MIDCAB CABG
p
Value
Number of vessels bypassed 1.4 6 0.8 3.3 6 1.0 , 0.001
Postoperative BB 65% 70% 0.46
Postoperative event* 19% 30% 0.08
Postoperative hospital stay (days) 6.6 6 3.6 8.8 6 5.8 0.001
*See Methods for details.
BB 5 beta-blockers; CABG 5 coronary artery bypass graft surgery.
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(p 5 0.15). The percentage of patients with recurrent
episodes of postoperative AF was similar in the MIDCAB
and CABG groups (52% for MIDCAB and 60% for
CABG, p 5 0.60). The duration of AF ranged between 1
and 300 h (median 5 9 h) for the MIDCAB group and
between 1 and 432 h (median 5 8 h) for the CABG group
(p 5 0.52). Eighty-seven percent of MIDCAB patients and
83% of CABG patients had AF for over 24 h (p 5 0.73).
Table 3 depicts the univariate predictors of postoperative
AF for the entire set of patients studied. Among nine
variables examined, seven were associated with postopera-
tive AF. Patients undergoing CABG were significantly
more likely to develop AF compared with MIDCAB
patients, OR 5 2.16, 95% (CI [confidence interval] 1.18–
3.95). The corrected OR using the approximation by Zhang
and Yu (28) was 1.71, 95% CI (1.17–2.59).
To control for possible confounding attributable to base-
line differences between CABG and MIDCAB patients, a
multivariate logistic regression analysis was performed on all
potentially significant variables to determine which variables
constituted independent predictors of postoperative AF
(Table 4). After adjustment for baseline clinical variables
and operative data, the method of revascularization was no
longer a significant predictor for the development of AF.
The uncorrected OR for developing AF in CABG versus
MIDCAB was 2.10, 95% CI (0.57–7.71). With correction,
the approximation to the RR was found to be 1.68, 95% CI
(0.63–3.03). An even lower estimate of the RR for AF in
the two patient groups was obtained when only four other
covariates are included in the logistic regression (left main
disease, absence of postoperative beta-blocker use, prior AF,
and postoperative event). The uncorrected OR for method
of revascularization was 1.9, 95% CI (0.78–4.62), whereas
correcting this to obtain the approximation to the RR
yielded 1.57, 95% CI (0.82–2.52).
Because patients with a prior history of AF are known to
be at higher risk for developing postoperative AF, we
performed a separate analysis, excluding patients with a
history of AF. When the data was re-analyzed by excluding
patients with a prior history of AF, the results were similar:
uncorrected OR (by multivariate analysis) for developing
AF in CABG versus MIDCAB: 2.06, 95% CI (0.52 to
7.94). A closer approximation to the RR for developing AF
in CABG versus MIDCAB (as explained in the previous
paragraph) gives an OR of 1.72, 95% CI (0.59 to 3.42).
DISCUSSION
Atrial fibrillation is a common and clinically important
postoperative arrhythmia and is associated with increased
morbidity (3,4,6) and prolonged postoperative hospital stay
(1–7), with a resultant increase in healthcare costs (1,7). In
fact, AF prolongs hospitalization independent of other
variables and is the most important remediable factor
responsible for excess hospitalization (7). The current study
demonstrates that although there is a significantly lower rate
of AF in MIDCAB patients, after adjusting for differences
in baseline and perioperative variables, postoperative AF
appears to occur at similar frequencies irrespective of the
method of revascularization. To our knowledge, this is the
first study to examine the rates of AF among MIDCAB and
CABG patients after accounting for differences in baseline
variables and perioperative course.
In the current study, rates of AF in MIDCAB patients
were high, with nearly one-fourth of patients developing
postoperative AF. In addition, the patterns of AF after
MIDCAB, including the rates of recurrent AF and the
longest duration of AF, paralleled CABG patients. This
information is important to healthcare professionals caring
for patients referred for MIDCAB procedures; it implies
that AF following MIDCAB is analogous to AF after
CABG, with an equal possibility for associated co-
morbidity and increases in healthcare costs. By recognizing
the potential for AF after MIDCAB, physicians will be
more likely to institute aggressive measures to prevent AF,
in an effort to decrease postoperative costs, and to avoid
associated complications.
Atrial fibrillation in MIDCAB patients: Earlier reports.
Prior investigators have reported that AF is uncommon
following MIDCAB, occurring in 0% to 24% of patients
(24–27). However, few studies have actually compared the
rates of postoperative AF in MIDCAB patients with that of
CABG patients (25–27). In one small report (25) in which
23 patients undergoing reoperation using the MIDCAB
approach were compared with a historical control of 12
patients undergoing conventional reoperative bypass sur-
gery, none of the MIDCAB patients developed postopera-
tive AF, compared with 7 (58%) of the CABG patients
(p , 0.001). In another report that retrospectively examined
Table 3. Results of Univariate Logistic Regression for
Postoperative AF
Clinical Variable OR (95% CI) p Value
Age* 1.05 (1.02, 1.08) 0.0024
Male gender 1.66 (0.87, 3.14) 0.12
Prior AF 9.87 (2.62, 37.27) 0.0007
LVEF* 0.99 (0.96, 1.01) 0.26
Left main disease 2.46 (1.23, 4.94) 0.01
CABG 2.16 (1.18, 3.95) 0.01
Number of vessels bypassed 1.34 (1.08, 1.68) 0.009
No postoperative BB 4.08 (2.18, 7.64) 0.0001
Postoperative event 2.84 (1.47, 5.46) 0.0018
*Odds ratios for continuous variables increase exponentially with each additional unit
increment.
AF 5 atrial fibrillation; BB 5 beta-blockers; CABG 5 coronary artery bypass
graft surgery; LVEF 5 left ventricular ejection fraction.
Table 4. Results of Multivariate Logistic Regression of
Postoperative AF
Clinical Variable OR (95% CI) p Value
Prior AF 14.50 (2.88, 73.06) 0.0012
No postoperative BB 5.61 (2.17, 14.50) 0.0004
Significant event 2.73 (1.04, 7.22) 0.04
AF 5 atrial fibrillation; BB 5 beta-blockers.
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a group of 34 MIDCAB patients and 747 CABG patients
(26), there was a trend toward a lower rate of AF in the
MIDCAB group compared with the CABG group (12% vs.
26%, p 5 0.06). Neither of these studies controlled for
potential differences in baseline variables between the two
surgical groups. Because we know that age (1,3–5,29,30)
and LVEF (31) can impact on risk for developing postop-
erative AF, it is important that these clinical characteristics
be considered when comparing rates of AF.
In a study by Cohn et al. (27) the investigators compared
55 MIDCAB patients with an age-matched group of 55
patients referred for conventional CABG. As a result of the
study design, the mean ages for both groups were similar;
however, important differences existed in other preoperative
variables and in the postoperative course between the two
groups. The incidence of postoperative AF was similar in
the MIDCAB and CABG groups (24% vs. 20%, p 5 0.64),
implying that age may be a significant factor to explain the
seemingly low rate of AF in MIDCAB patients.
Mechanisms of postoperative atrial fibrillation. Certain
patient subsets are at known higher risk for developing
postoperative AF. Although age is probably the most
important risk factor for developing postoperative AF (1,3–
5,29,30) compromised left ventricular function has been
shown to independently predict the development of AF
after cardiac surgery (31). In the current study, important
differences were seen in the mean age and in LVEF of
CABG and MIDCAB patients, indicating that the CABG
group may have been at higher risk for developing postop-
erative AF.
Among patients with an underlying predisposition to
develop postoperative AF, this arrhythmia is likely triggered
by factors related to cardiac surgery and the postoperative
recovery. Clinical observations have demonstrated the im-
portance of adrenergic tone as a determinant of postopera-
tive AF (32–36): patients experiencing AF after cardiac
surgery have higher levels of norepinephrine than do those
who remain in sinus rhythm (30), and studies of heart rate
variability have indicated that sympathetic activity precedes
AF after CABG (33).
In the current study, the absence of postoperative beta-
blockers was independently associated with higher rates of
postoperative AF, demonstrating the importance of control-
ling adrenergic tone after surgery. The similar adjusted rates
of AF for MIDCAB and CABG patients implies that
increased adrenergic tone is an important inciting factor for
developing AF in both surgical groups. It is possible that
adrenergic tone may be heightened in MIDCAB patients,
despite the less invasive surgery, owing to a relatively higher
degree of postoperative discomfort/pain related to thoracot-
omy, and earlier reversal of deep anesthesia.
Atrial necrosis or ischemia (4,11–13), electrolyte abnor-
malities occurring as a result of cardiopulmonary bypass
(14–16), and pericarditis (17,18) have all been proposed
as potential triggers for postoperative AF. However, exces-
sive myocardial manipulation (which may predispose to
pericarditis), atriotomy (which can contribute to atrial
necrosis) and cardiopulmonary bypass (which can result in
atrial ischemia or electrolyte abnormalities) are absent in
MIDCAB procedures. Despite their absence, the rates of
AF after MIDCAB are similar to that of CABG patients.
Although these stimuli for developing postoperative AF
may be important among CABG patients, the equal fre-
quency of AF in MIDCAB and CABG patients implies
that other triggers for AF likely predominate.
Conclusions. We conclude that the adjusted rates of AF
are similar after MIDCAB and CABG. The fact of similar
frequencies of AF for the two surgical techniques raises the
possibility that similar inciting factors are at work.
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